These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8133463)

  • 1. Formed and preformed metabolite excretion clearances in liver, a metabolite formation organ: studies on enalapril and enalaprilat in the single-pass and recirculating perfused rat liver.
    de Lannoy IA; Barker F; Pang KS
    J Pharmacokinet Biopharm; 1993 Aug; 21(4):395-422. PubMed ID: 8133463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined recirculation of the rat liver and kidney: studies with enalapril and enalaprilat.
    de Lannoy IA; Pang KS
    J Pharmacokinet Biopharm; 1993 Aug; 21(4):423-56. PubMed ID: 8133464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A physiological model for renal drug metabolism: enalapril esterolysis to enalaprilat in the isolated perfused rat kidney.
    de Lannoy IA; Hirayama H; Pang KS
    J Pharmacokinet Biopharm; 1990 Dec; 18(6):561-87. PubMed ID: 2177788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal handling of enalapril and enalaprilat: studies in the isolated red blood cell-perfused rat kidney.
    de Lannoy IA; Nespeca R; Pang KS
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1211-22. PubMed ID: 2557416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of a diffusional barrier on metabolite kinetics: enalaprilat as a generated versus preformed metabolite.
    de Lannoy IA; Pang KS
    Drug Metab Dispos; 1986; 14(5):513-20. PubMed ID: 2876855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of enalapril and its diacid metabolite, enalaprilat, in a perfused rat liver preparation. Presence of a diffusional barrier for enalaprilat into hepatocytes.
    Pang KS; Cherry WF; Terrell JA; Ulm EH
    Drug Metab Dispos; 1984; 12(3):309-13. PubMed ID: 6145558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of diffusional barriers on drug and metabolite kinetics.
    de Lannoy IA; Pang KS
    Drug Metab Dispos; 1987; 15(1):51-8. PubMed ID: 2881759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer of enalaprilat across rat liver cell membranes is barrier limited.
    Schwab AJ; Barker F; Goresky CA; Pang KS
    Am J Physiol; 1990 Mar; 258(3 Pt 1):G461-75. PubMed ID: 2156443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in excretion of hippurate, as a metabolite of benzoate and as an administered species, in the single-pass isolated perfused rat kidney explained.
    Geng W; Pang KS
    J Pharmacol Exp Ther; 1999 Feb; 288(2):597-606. PubMed ID: 9918564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esterases for enalapril hydrolysis are concentrated in the perihepatic venous region of the rat liver.
    Pang KS; Barker F; Cherry WF; Goresky CA
    J Pharmacol Exp Ther; 1991 Apr; 257(1):294-301. PubMed ID: 1850468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular and not intraluminal esterolysis of enalapril in kidney. Studies with the single pass perfused nonfiltering rat kidney.
    Sirianni GL; Pang KS
    Drug Metab Dispos; 1998 Apr; 26(4):324-31. PubMed ID: 9531519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequestered endoplasmic reticulum space for sequential metabolism of salicylamide. Coupling of hydroxylation and glucuronidation.
    Tirona RG; Pang KS
    Drug Metab Dispos; 1996 Aug; 24(8):821-33. PubMed ID: 8869815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of enalapril in the perfused rat intestine-liver preparation: absorption, metabolism and first-pass effect.
    Pang KS; Cherry WF; Ulm EH
    J Pharmacol Exp Ther; 1985 Jun; 233(3):788-95. PubMed ID: 2989498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of esterolysis of enalapril by paraoxon increases the urinary clearance in isolated perfused rat kidney.
    Sirianni GL; Pang KS
    Drug Metab Dispos; 1999 Aug; 27(8):931-6. PubMed ID: 10421621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of cysteinyl leukotrienes in non-recirculating rat liver perfusion. Hepatocyte heterogeneity in uptake and biliary excretion.
    Wettstein M; Gerok W; Häussinger D
    Eur J Biochem; 1989 Apr; 181(1):115-24. PubMed ID: 2565811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organ clearance concepts: new perspectives on old principles.
    Sirianni GL; Pang KS
    J Pharmacokinet Biopharm; 1997 Aug; 25(4):449-70. PubMed ID: 9561488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enalaprilat handling by the kidney: barrier-limited cell entry.
    Schwab AJ; de Lannoy IA; Goresky CA; Poon K; Pang KS
    Am J Physiol; 1992 Nov; 263(5 Pt 2):F858-69. PubMed ID: 1332505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vectorial transport of enalapril by Oatp1a1/Mrp2 and OATP1B1 and OATP1B3/MRP2 in rat and human livers.
    Liu L; Cui Y; Chung AY; Shitara Y; Sugiyama Y; Keppler D; Pang KS
    J Pharmacol Exp Ther; 2006 Jul; 318(1):395-402. PubMed ID: 16627748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of multidrug resistance-associated protein 4 in the basolateral efflux of hepatically derived enalaprilat.
    Ferslew BC; Köck K; Bridges AS; Brouwer KL
    Drug Metab Dispos; 2014 Sep; 42(9):1567-74. PubMed ID: 24958844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transport is not rate-limiting in morphine glucuronidation in the single-pass perfused rat liver preparation.
    Doherty MM; Poon K; Tsang C; Pang KS
    J Pharmacol Exp Ther; 2006 May; 317(2):890-900. PubMed ID: 16464965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.